We are live on
!
Find out more
IMI
Intermolecular, Inc.
IMI
IMI
Delisted
IMI was delisted on the 19th of September, 2019.
23 hedge funds and large institutions have $17.4M invested in Intermolecular, Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% less capital invested
Capital invested by funds: $17.9M → $17.4M (-$516K)
8% less funds holding
Funds holding: 25 → 23 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.42K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.18K |
| 3 |
Renaissance Technologies
New York
|
+$1.84K |
| 4 |
Morgan Stanley
New York
|
+$184 |
Top Sellers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$127K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$78K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$67.5K |
| 4 |
BlackRock
New York
|
-$40.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$26K |
